Drug intelligence / Profile preview

Radix Rehmanniae Oligosaccharides

Development stage: Unknown
Administration: Oral

Overview

Radix Rehmanniae Oligosaccharides are derived from the root of *Rehmannia glutinosa*, a plant used in Traditional Chinese Medicine. These oligosaccharides, including raffinose family oligosaccharides like stachyose and verbascoside, have been reported to have immune-stimulating properties and may support beneficial intestinal bacteria as prebiotics. They are also noted for potential hypoglycemic effects and neuroprotective properties.

Other names: Rehmannia Oligosaccharides

Targets

INSR (Insulin receptor)

Beyond the preview

Go deeper on Radix Rehmanniae Oligosaccharides.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Radix Rehmanniae Oligosaccharides.

Explore the full profile